Tiziana to participate in january investor meetings

New york, dec. 16, 2022 (globe newswire) -- tiziana life sciences ltd. (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company enabling breakthrough cns immunomodulation approaches to enhance the functionality of treg-based therapies, announced today that the company plans to present at the biotech showcase and host institutional investor and partnering meetings at this event, as well as at the lifesci corporate access event. both in-person events are taking place january 9-10, 2023 in san francisco, california.
TLSA Ratings Summary
TLSA Quant Ranking